Armstrong, E. J., Chen, D. C., Singh, G. D., Amsterdam, E. A., & Laird, J. R. (2015). Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Vascular medicine (London, England), 20(3), 237-244. https://doi.org/10.1177/1358863X15574321
Citácia podle Chicago (17th ed.)Armstrong, Ehrin J., Debbie C. Chen, Gagan D. Singh, Ezra A. Amsterdam, a John R. Laird. "Angiotensin-converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Is Associated with Reduced Major Adverse Cardiovascular Events Among Patients with Critical Limb Ischemia." Vascular Medicine (London, England) 20, no. 3 (2015): 237-244. https://doi.org/10.1177/1358863X15574321.
Citácia podľa MLA (8th ed.)Armstrong, Ehrin J., et al. "Angiotensin-converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Is Associated with Reduced Major Adverse Cardiovascular Events Among Patients with Critical Limb Ischemia." Vascular Medicine (London, England), vol. 20, no. 3, 2015, pp. 237-244, https://doi.org/10.1177/1358863X15574321.